Filed: 2/9/2024ACC: 0001104659-24-012910
📋 What this filing means
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $839.75M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$839.75M
Total AUM (reported)
70.12M
Total Shares
Allocation by class
COMMON STOCK$839.75M100.0%
Portfolio Concentration
Top 3$428.21M51.0%
4–10$381.62M45.4%
11–25$29.92M3.6%
Top 3 weight
51.0%
Top 10 weight
96.4%
Voting Authority Distribution
Total shares with voting rights: 70.12M
Sole
Full voting authority
70.12M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole16
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings16
Rows:
Kymera Therapeutics, Inc.
SOLEShares5.86M
TypeSH
Market value$149.15M
17.76%
Sole
5.86M
Shared
0.00
None
0.00
Disc Medicine, Inc.
SOLEShares2.56M
TypeSH
Market value$147.59M
17.58%
Sole
2.56M
Shared
0.00
None
0.00
Dyne Therapeutics, Inc.
SOLEShares9.89M
TypeSH
Market value$131.48M
15.66%
Sole
9.89M
Shared
0.00
None
0.00
Third Harmonic Bio, Inc.
SOLEShares10.91M
TypeSH
Market value$119.66M
14.25%
Sole
10.91M
Shared
0.00
None
0.00
Day One Biopharmaceuticals, Inc.
SOLEShares7.61M
TypeSH
Market value$111.08M
13.23%
Sole
7.61M
Shared
0.00
None
0.00
Korro Bio, Inc.
SOLEShares1.12M
TypeSH
Market value$53.65M
6.39%
Sole
1.12M
Shared
0.00
None
0.00
Aerovate Therapeutics, Inc.
SOLEShares2.04M
TypeSH
Market value$46.15M
5.50%
Sole
2.04M
Shared
0.00
None
0.00
Vigil Neuroscience, Inc.
SOLEShares5.84M
TypeSH
Market value$19.73M
2.35%
Sole
5.84M
Shared
0.00
None
0.00
Replimune Group, Inc.
SOLEShares2.10M
TypeSH
Market value$17.69M
2.11%
Sole
2.10M
Shared
0.00
None
0.00
Generation Bio, Co.
SOLEShares8.28M
TypeSH
Market value$13.66M
1.63%
Sole
8.28M
Shared
0.00
None
0.00
Ikena Oncology, Inc.
SOLEShares5.02M
TypeSH
Market value$9.89M
1.18%
Sole
5.02M
Shared
0.00
None
0.00
Akero Therapeutics, Inc.
SOLEShares359.25K
TypeSH
Market value$8.39M
1.00%
Sole
359.25K
Shared
0.00
None
0.00
AvroBio, Inc.
SOLEShares4.54M
TypeSH
Market value$6.18M
0.74%
Sole
4.54M
Shared
0.00
None
0.00
Dianthus Therapeutics, Inc.
SOLEShares236.98K
TypeSH
Market value$2.46M
0.29%
Sole
236.98K
Shared
0.00
None
0.00
Xilio Therapeutics, Inc.
SOLEShares2.76M
TypeSH
Market value$1.52M
0.18%
Sole
2.76M
Shared
0.00
None
0.00
Spero Therapeutics, Inc.
SOLEShares1.01M
TypeSH
Market value$1.49M
0.18%
Sole
1.01M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc.SOLE | Common Stock | 5.86M | SH | $149.15M 17.76% | 5.86M | 0.00 | 0.00 |
Disc Medicine, Inc.SOLE | Common Stock | 2.56M | SH | $147.59M 17.58% | 2.56M | 0.00 | 0.00 |
Dyne Therapeutics, Inc.SOLE | Common Stock | 9.89M | SH | $131.48M 15.66% | 9.89M | 0.00 | 0.00 |
Third Harmonic Bio, Inc.SOLE | Common Stock | 10.91M | SH | $119.66M 14.25% | 10.91M | 0.00 | 0.00 |
Day One Biopharmaceuticals, Inc.SOLE | Common Stock | 7.61M | SH | $111.08M 13.23% | 7.61M | 0.00 | 0.00 |
Korro Bio, Inc.SOLE | Common Stock | 1.12M | SH | $53.65M 6.39% | 1.12M | 0.00 | 0.00 |
Aerovate Therapeutics, Inc.SOLE | Common Stock | 2.04M | SH | $46.15M 5.50% | 2.04M | 0.00 | 0.00 |
Vigil Neuroscience, Inc.SOLE | Common Stock | 5.84M | SH | $19.73M 2.35% | 5.84M | 0.00 | 0.00 |
Replimune Group, Inc.SOLE | Common Stock | 2.10M | SH | $17.69M 2.11% | 2.10M | 0.00 | 0.00 |
Generation Bio, Co.SOLE | Common Stock | 8.28M | SH | $13.66M 1.63% | 8.28M | 0.00 | 0.00 |
Ikena Oncology, Inc.SOLE | Common Stock | 5.02M | SH | $9.89M 1.18% | 5.02M | 0.00 | 0.00 |
Akero Therapeutics, Inc.SOLE | Common Stock | 359.25K | SH | $8.39M 1.00% | 359.25K | 0.00 | 0.00 |
AvroBio, Inc.SOLE | Common Stock | 4.54M | SH | $6.18M 0.74% | 4.54M | 0.00 | 0.00 |
Dianthus Therapeutics, Inc.SOLE | Common Stock | 236.98K | SH | $2.46M 0.29% | 236.98K | 0.00 | 0.00 |
Xilio Therapeutics, Inc.SOLE | Common Stock | 2.76M | SH | $1.52M 0.18% | 2.76M | 0.00 | 0.00 |
Spero Therapeutics, Inc.SOLE | Common Stock | 1.01M | SH | $1.49M 0.18% | 1.01M | 0.00 | 0.00 |